Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.6 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |